Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 2)

Ascites (Phase 3)

Breast Neoplasms (Phase 2)

Bronchiectasis (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 2)

Cystic Fibrosis (Phase 3)

Diabetes Mellitus, Type 1 (Phase 3)

Diabetic Nephropathies (Phase 3)

Fibrosis (Phase 3)

Graft vs Host Disease (Phase 3)

Idiopathic Pulmonary Fibrosis (Phase 3)

Leukemia (Phase 3)

Leukemia, Lymphoid (Phase 3)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Myelodysplastic Syndromes (Phase 3)

Ovarian Neoplasms (Phase 2)

Peritoneal Neoplasms (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)

Preleukemia (Phase 3)

Pulmonary Fibrosis (Phase 3)

Stomach Neoplasms (Phase 2)

Syndrome (Phase 3)

Vascular Diseases (Phase 3)